Healthcare providers hold a pivotal role in identifying and addressing chronic kidney disease (CKD) risks among their patients. 1 in 3, or 33%, of adults in the United States are at risk for kidney disease, and most don’t know. This risk is even more prevalent among certain demographic groups, including Hispanic, Black, American Indian, and Middle Eastern North African individuals.
CKD often progresses silently. It is often asymptomatic in its early stages, resulting in many patients are unaware they have the disease until it has progressed. Furthermore, several health conditions significantly heighten the risk, such as type 2 diabetes, high blood pressure, obesity, and a family history of kidney disease.
In partnership with the National Kidney Foundation of Michigan, we are urging healthcare providers to prioritize CKD testing and engage in open dialogues with their patients. Testing and effective patient-provider communication is equally crucial. Beyond conveying diagnostic results, discussions should delve into risk factors, lifestyle modifications, and shared decision-making processes. Empowering patients with knowledge and involving them in their care journey are essential steps toward mitigating CKD’s impact. To begin these conversations, encourage patients to assess their risk by completing a brief questionnaire available at kidneymi.org/kidneyquiz.
Let’s unite in our efforts to raise awareness, advocate for early detection, and foster collaborative relationships with patients. By embracing proactive measures and promoting informed dialogue, we can make significant strides in combating the silent threat of CKD and improving patient outcomes. Visit nkfm.org/provideredu to get started.
